文献速递产科

经皮神经电刺激用于剖宫产术后疼痛控制:一项随机对照试验

Transcutaneous Electrical Nerve Stimulation for Post-Cesarean Birth Pain Control: A Randomized Controlled Trial.
PubMed 文献 · Obstet Gynecol · 2022-07-06

该随机双盲安慰剂对照试验纳入180例剖宫产产妇,评估经皮神经电刺激(TENS)是否减少术后阿片类药物使用。主要结局为术后前60小时阿片类药物用量,活性TENS组中位数7.5吗啡毫克当量 vs 安慰剂TENS组0(P=.31),无显著差异;疼痛评分、满意度及住院时长亦无显著差异,无安慰剂效应证据。

要点

  • 剖宫产术后使用TENS未改变住院期间阿片类药物用量、疼痛评分或术后住院时长。
  • 活性TENS组术后前60小时阿片用量中位数7.5 vs 安慰剂TENS组0(P=.31),无显著差异。
  • 无TENS组与安慰剂TENS组阿片用量相似(P=.57),无安慰剂效应证据。

核心结论

  • 剖宫产术后使用TENS未改变住院期间阿片类药物用量、疼痛评分或术后住院时长。
  • 无证据表明TENS对阿片用量或疼痛评分存在安慰剂效应。

研究设计与样本

  • 随机双盲安慰剂对照试验,纳入180例剖宫产产妇,每组60例(活性TENS组、安慰剂TENS组、无TENS组)。
  • 主要结局为术后前60小时阿片类药物用量;次要结局包括每个术后日的疼痛评分和疼痛控制满意度、术后住院时长及TENS不良反应。
  • 按意向性分析;假设阿片用量减少25%、脱落率10%,每组60例可提供80%把握度。

主要发现

  • 术后前60小时阿片用量中位数(四分位距)以吗啡毫克当量计:活性TENS组7.5(0-30) vs 安慰剂TENS组0(0-22.5),P=.31。
  • 疼痛评分、疼痛控制满意度及术后住院时长在各组间无显著差异。
  • 无TENS组术后前60小时阿片用量中位数(四分位距)7.5(0-21.9),与安慰剂TENS组相似(P=.57)。
  • 无TENS组与安慰剂TENS组在疼痛评分或疼痛控制满意度方面亦无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate whether transcutaneous electrical nerve stimulation (TENS) reduces opioid use after cesarean birth. METHODS: We conducted a randomized, double-blind, placebo-controlled trial of TENS after cesarean birth, with the primary outcome of opioid use during the first 60 hours postoperatively. Secondary outcomes included pain scores and satisfaction with pain control on each postoperative day, duration of postoperative hospitalization, and adverse effects of TENS. We estimated 60 patients in each arm for 80% power to detect a 25% decrease in opioid use, assuming 10% attrition. To assess for a placebo effect, an additional 60 patients were randomized to no TENS during recruitment for secondary analyses comparing opioid use, pain scores, and pain control satisfaction between no TENS and placebo TENS. Analysis was by intention-to-treat. RESULTS: From January 2020 through March 2021, we enrolled 180 participants-60 per group. Baseline characteristics were similar across groups. Median (interquartile range) opioid consumption in the first 60 hours postoperatively, in morphine milligram equivalents, was 7.5 (0-30) with active TENS and 0 (0-22.5) with placebo TENS (P=.31). There were no significant differences in pain scores, satisfaction with pain control, or postoperative length of stay. In the no TENS group, median (interquartile range) opioid consumption in the first 60 hours postoperatively was 7.5 (0-21.9), similar to that in the placebo group (P=.57). There were also no significant differences in pain scores or pain control satisfaction between participants allocated to no TENS and those allocated to placebo TENS. CONCLUSION: Use of TENS after cesarean birth did not change hospital opioid consumption, pain scores, or length of postoperative stay. There was no evidence for a placebo effect of TENS on opioid use or pain scores. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov: NCT04399707. FUNDING SOURCE: Cardinal Health.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Kurata NB, Ghatnekar RJ, Mercer E, et al. Transcutaneous Electrical Nerve Stimulation for Post-Cesarean Birth Pain Control: A Randomized Controlled Trial. Obstet Gynecol. 2022. PMID: 35852266. doi:10.1097/AOG.0000000000004798

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。